Want to join the conversation?
$JNPR forecast 4Q15 revenues plus or minus $20MM of $1,290MM. Non-GAAP net income per share will range between $0.57 and $0.60 on a diluted basis assuming a flat share count from 3Q15 and a non-GAAP tax rate of approx. 25.5% for 4Q15, assuming no renewal of the R&D tax credit for 2015.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?